Effects of low altitude on exercise performance in patients with congestive heart failure after healing of acute myocardial infarction

American Journal of Cardiology

Volumn 83, Issue 3, 1999, Pages 383-387

  Abinader, Edward G ^a   Sharif, Dawod S ^a   Goldhammer, Ehud ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ALTITUDE; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HUMAN; ISRAEL; LUNG ALVEOLUS OXYGEN TENSION; LUNG MINUTE VOLUME; MALE; OXIMETRY; OXYGEN CONSUMPTION; OXYGEN SATURATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

ALTITUDE; BLOOD PRESSURE; CARDIAC OUTPUT; CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; EXERCISE TEST; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; ISRAEL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIMETRY;

EID: 0033081885     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00873-X     Document Type: Article

References (17)

1. Clark A.L., Poole-Wilson P.A., Coats A.J.S. Exercise limitation in chronic heart failure central role of the periphery . J Am Coll Cardiol. 28:1996;1092-1102.
2. Sullivan M.J., Higginbotham G.T., Cobb F.R. Increased exercise ventilation in patients with chronic heart failure intact ventilatory control despite hemodynamic and pulmonary abnormalities . Circulation. 77:1988;552-559.
3. Weber K.T., Kinasewitz G.T., Janicki J.S., Fishman A.P. Oxygen utilization and ventilation during exercise in patients with chronic heart failure. Circulation. 65:1982;1213-1223.
4. Bannister R.G., Cunnigham D.J. The effects on the respiration and performance during exercise of adding oxygen to the inspired air. J Physiol (Lond). 125:1954;118-137.
5. King A., Cooke N., Leitch G., Flenley D. The effects of 30% oxygen on the respiratory response to treadmill exercise in chronic respiratory failure. Clin Sci. 44:1973;151-162.
6. Moore D.P., Weston A.R., Hughes J.M.B., Oakley C.M., Cleland J.G.F. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet. 339:1992;850-853.
7. Shani J., Kushelevsky A.P., Harari M., Even-Paz Z. Sustained decrease of blood pressure in psoriatic patients during treatment at the Dead Sea. Pharmacol Res. 31:1995;335-340.
8. Kremer M.R., Springer C., Berkman N., Bar-Yishay E., Avital A., Mandelberg A., Effron D., Godfrey S. Effects of natural oxygen enrichment at low altitude on oxygen-dependent patients with end-stage lung disease. Ann Intern Med. 121:1994;658-662.
9. Morgan B.J., Alexander J.K., Nicoli S.A., Brammel H.L. The patient with coronary heart disease at altitude observations during acute exposure to 3100 meters . J Wilderness Med. 1:1990;147-153.
10. Sahn D.J., De Maria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements . Circulation. 58:1987;1072-1083.
11. Lipkin D.P., Scriven A.J., Crake T., Poole Wilson P.A. Six minute walk test for assessing exercise capacity in chronic heart failure. Br Med J. 296:1986;653-655.
12. Borg G., Linderholm H. Exercise performance and perceived exertion in patients with coronary insufficiency, arterial hypertension and vasoregulatory asthenia. Acta Med Scand. 187:1970;17-24.
13. Shani I., Barak S., Rant M., Levi D., Feifer V., Schlesinger T., Avroch M.V., Robberecht H., Van Grieken R. Serum Bromine levels in psoriasis. Pharmacology. 25:1982;279-302.
14. Kushelevsky A.P., Harari M., Hristakieva E., Shani J. Climatotherapy of psoariasis and hypertnsion in elderly patients at the Dead Sea. Pharmacolog Res. 34:1996;87-91.
15. Vigorito C., Giordano A., Ferraro P. Hemodynamic effects of magnesium sulfate on the normal human heart. Am J Cardiol. 67:1991;1435-1437.
16. Rasmussen H., Larsen O., Meier K., Larsen J. Hemodynamic effects of intravenously administered magnesium on patients with ischemic heart disease. Clin Cardiol. 11:1988;824-828.
17. Benzer W., Schmid P., Maehr G., Drexel H. Effects of intravenous magnesium chloride reverses left ventricular end-diastolic pressure in coronary artery disease. Am J Cardiol. 77:1996;638-640.